Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000192877 | SCV000248266 | uncertain significance | not specified | 2014-06-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000532367 | SCV000650848 | benign | Niemann-Pick disease, type C1 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000192877 | SCV000700540 | likely benign | not specified | 2016-09-27 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000532367 | SCV000744739 | likely benign | Niemann-Pick disease, type C1 | 2017-06-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000532367 | SCV001282152 | uncertain significance | Niemann-Pick disease, type C1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Ce |
RCV000675555 | SCV001502261 | likely benign | not provided | 2024-10-01 | criteria provided, single submitter | clinical testing | NPC1: BP4, BP7 |
Ambry Genetics | RCV002453707 | SCV002616644 | likely benign | Inborn genetic diseases | 2022-03-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003891763 | SCV000303382 | benign | NPC1-related disorder | 2021-02-01 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome Diagnostics Laboratory, |
RCV000532367 | SCV000745693 | likely benign | Niemann-Pick disease, type C1 | 2016-04-22 | no assertion criteria provided | clinical testing | |
Mayo Clinic Laboratories, |
RCV000675555 | SCV000801246 | likely benign | not provided | 2017-11-13 | no assertion criteria provided | clinical testing | |
Natera, |
RCV000532367 | SCV001463697 | benign | Niemann-Pick disease, type C1 | 2020-01-16 | no assertion criteria provided | clinical testing | |
Clinical Genetics, |
RCV000192877 | SCV001922294 | benign | not specified | no assertion criteria provided | clinical testing |